Brief: Iconovo To Reduce Cost Base By SEK 14-16 Mln Annually
24/04/2025 07:43
April 24 (Reuters) - Iconovo AB ICO.ST: PLANS ORGANIZATIONAL CHANGE TO REDUCE COST BASE BY SEK 14-16 MILLION ANNUALLY TO FOCUS ON COMMERCIALIZATION OF EXISTING PRODUCTS AND SEMAGLUTIDE DEVELOPMENT TO INITIATE UNION NEGOTIATIONS FOR WORKFORCE REDUCTION BY TEN POSITIONS NON-RECURRING COSTS OF SEK 1 MILLION TO BE RECOGNIZED IN Q3 2025 RESULTS TO SIGN REGIONAL LICENSE AGREEMENTS AND DEVELOP INTRANASAL SEMAGLUTIDE PRODUCTS Source text: ID:nMFN66wMN1 Further company coverage: ICO.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))